For the year ending 2025-12-31, LCID had -$566,139K decrease in cash & cash equivalents over the period. -$3,800,070K in free cash flow.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net loss | -2,698,051 | -2,713,942 | -2,828,420 | -1,304,460 |
| Depreciation and amortization | 451,243 | 295,337 | 233,531 | 186,583 |
| Amortization of insurance premium | 35,467 | 33,330 | 39,507 | 35,620 |
| Non-cash operating lease cost | 47,527 | 30,765 | 26,201 | 19,711 |
| Stock-based compensation | 271,275 | 285,872 | 257,283 | 423,500 |
| Inventory and firm purchase commitments write-downs | 799,078 | 590,198 | 906,069 | 569,479 |
| Change in fair value of contingent forward contract liability | - | - | 0 | 0 |
| Change in fair value of stock warrants liability-Convertible Preferred Stock Warrant Liability | - | - | 0 | 0 |
| Change in fair value of common stock warrant liability-Common Stock Warrant Liability | -19,514 | -34,150 | -86,926 | -1,254,218 |
| Change in fair value of equity securities of a related party | -15,785 | -43,057 | 5,999 | - |
| Change in fair value of derivative liabilities associated with redeemable convertible preferred stock (related party) | 623,225 | 155,350 | - | - |
| Net accretion of investment discounts/premiums | 23,631 | 76,739 | 105,432 | - |
| Gain on extinguishment of debt | 121,765 | - | - | - |
| Other non-cash items | -20,026 | -5,983 | -34,205 | 10,342 |
| Accounts receivable (including (62,631), (22,383), and (35,526) from a related party for the years ended december31, 2025, 2024, and 2023, respectively) | 65,690 | 61,279 | 32,509 | 16,498 |
| Inventory | 1,449,071 | 334,242 | 658,010 | 1,256,349 |
| Prepaid expenses | 41,972 | 16,675 | 45,641 | 28,822 |
| Other current assets | - | 141,110 | -4,758 | 43,591 |
| Other noncurrent assets | - | 62,759 | 121,790 | 43,230 |
| Other assets | 155,266 | - | - | - |
| Accounts payable | 318,456 | 34,756 | -139,519 | 180,469 |
| Accrued compensation | - | - | 29,172 | 30,958 |
| Operating lease liability | - | - | - | -15,482 |
| Other current liabilities | - | 131,627 | -71,680 | 269,386 |
| Other long-term liabilities (including 4,900, 107,763, and nil associated with a related party for the years ended december31, 2024, 2023, and 2022, respectively) | - | 125,647 | 75,447 | 31,028 |
| Other liabilities (including 2,100, 4,900, and 107,763 associated with a related party for the years ended december31, 2025, 2024, and 2023, respectively) | 307,416 | - | - | - |
| Net cash used in operating activities | -2,931,912 | -2,019,674 | -2,489,753 | -2,226,258 |
| Purchases of property, plant and equipment (including (225,864), (164,683), and (80,511) from a related party for the years ended december31, 2025, 2024, and 2023, respectively) | 868,158 | 883,841 | 910,644 | 1,074,852 |
| Purchases of investments (including (30,000), (35,000), and nil from a related party for the years ended december31, 2025, 2024, and 2023, respectively) | 309,557 | 4,622,890 | 3,998,282 | 3,854,129 |
| Proceeds from maturities of investments (including 15,000 from a related party for the year ended december31, 2025, and nil for the years ended december31, 2024 and 2023) | 2,654,090 | 4,112,084 | 3,720,890 | 1,149,714 |
| Proceeds from sale of property, plant and equipment | - | - | - | 0 |
| Proceeds from sale of investments | 0 | 100,193 | 148,388 | - |
| Proceeds from sale of short term investments | - | - | - | 0 |
| Proceeds from government grant | 0 | 0 | 97,500 | 97,267 |
| Proceeds from insurance claims | - | - | - | 323 |
| Other investing activities | -2,054 | 0 | 4,827 | - |
| Net cash provided by (used in) investing activities | 1,478,429 | -1,294,454 | -946,975 | -3,681,677 |
| Proceed from issuance of convertible notes, net of issuance costs | - | - | 0 | 0 |
| Payment for issuance costs-Convertible Debt | - | - | 0 | 0 |
| Proceeds from issuance of common stock-At The Market Offering | - | 0 | 0 | 594,317 |
| Proceeds from issuance of common stock-A2022Subscription Agreement | - | 0 | 0 | - |
| Proceeds from issuance of redeemable convertible preferred stock to a related party-Series ARedeemable Convertible Preferred Stock | 0 | 1,000,000 | - | - |
| Payments of issuance costs for redeemable convertible preferred stock-Series ARedeemable Convertible Preferred Stock | 0 | - | - | - |
| Proceeds from issuance of redeemable convertible preferred stock to a related party-Series BRedeemable Convertible Preferred Stock | 0 | 750,000 | - | - |
| Payments of issuance costs for redeemable convertible preferred stock-Series BRedeemable Convertible Preferred Stock | 0 | - | - | - |
| Proceeds from issuance of common stock-A2025Subscription Agreement | 300,000 | - | - | - |
| Payments of issuance costs for the 2025 subscription agreement-A2025Subscription Agreement | 278 | - | - | - |
| Proceeds from convertible debt-A2031Notes | 975,000 | - | - | - |
| Payment for issuance costs-A2031Notes | 11,675 | - | - | - |
| Proceeds from convertible debt-A2030Notes | 1,100,000 | - | - | - |
| Payment for issuance costs-A2030Notes | 18,090 | - | - | - |
| Purchase of capped call options | -118,250 | - | - | - |
| Repurchases of 2026 notes | 1,679,609 | - | - | - |
| Proceeds from issuance of common stock-A2024Underwriting Agreement | 0 | 718,357 | - | - |
| Proceeds from issuance of common stock-A2024Subscription Agreement | 0 | 1,025,660 | - | - |
| Proceeds from issuance of common stock-Over Allotment Option | - | - | 1,184,224 | - |
| Proceeds from issuance of common stock-A2023Underwriting Agreement | 0 | 0 | - | - |
| Proceeds from issuance of common stock-A2023Subscription Agreement | 0 | 0 | 1,812,641 | - |
| Proceeds from borrowings | - | - | 62,911 | 29,818 |
| Proceeds from borrowings from a related party | 341,240 | 79,844 | - | - |
| Repayments for borrowings | - | - | 0 | 20,223 |
| Repayment of borrowings to a related party | 0 | 25,856 | - | - |
| Proceeds from failed sale-leaseback transaction | - | 0 | 0 | 31,700 |
| Repurchase of series b convertible preferred stock-Series BPreferred Stock | - | - | 0 | 0 |
| Repurchase of series b convertible preferred stock-Series CPreferred Stock | - | - | - | 0 |
| Proceeds from issuance of convertible preferred stock-Series DPreferred Stock | - | - | 0 | 0 |
| Proceeds from issuance of convertible preferred stock-Series EPreferred Stock | - | - | 0 | 0 |
| Proceeds from exercise of stock options | 2,342 | 4,883 | 10,343 | 17,788 |
| Proceeds from the exercise of public warrants | - | - | 0 | 0 |
| Proceeds from the reverse capitalization | - | - | 0 | 0 |
| Payments of issuance costs for redeemable convertible preferred stock-Series ARedeemable Convertible Preferred Stock | - | 2,351 | - | - |
| Payment of transaction costs related to the reverse recapitalization | - | - | 0 | 0 |
| Proceeds from issuance of common stock-Private Placement | - | - | - | 915,000 |
| Payments of issuance costs for redeemable convertible preferred stock-Series BRedeemable Convertible Preferred Stock | - | 641 | - | - |
| Proceeds from employee stock purchase plan | 22,808 | 19,208 | 23,836 | 24,562 |
| Proceeds from short-term insurance financing note | - | - | 0 | 0 |
| Payment for issuance costs | - | 6,244 | - | - |
| Treasury stock repurchase | - | - | 0 | 0 |
| Payment for short-term insurance financing note | - | 0 | 0 | 15,330 |
| Tax withholding payments for net settlement of employee awards | 12,911 | 10,021 | 17,615 | 218,789 |
| Payments for finance lease liabilities | 3,510 | 3,166 | 5,425 | 4,977 |
| Payment for issuance costs-Line Of Credit | - | - | 0 | 6,631 |
| Payments for credit facility issuance costs | 9,723 | - | - | - |
| Net cash provided by financing activities | 887,344 | 3,549,673 | 3,070,915 | 1,347,235 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | -566,139 | 235,545 | -365,813 | -4,560,700 |
| Beginning cash, cash equivalents, and restricted cash | 1,607,052 | 1,371,507 | 1,737,320 | 6,298,020 |
| Ending cash, cash equivalents, and restricted cash | 1,040,913 | 1,607,052 | 1,371,507 | 1,737,320 |
Lucid Group, Inc. (LCID)
Lucid Group, Inc. (LCID)